Bio-Matrix and Vibragene Sign Letter of Intent for Genetic Testing
Posted on: Friday, 4 April 2008, 06:00 CDT
Bio-Matrix Scientific Group has entered into a letter of intent with Vibragene, an anti-aging and genetic analysis company.
Pursuant to the letter of intent, it is proposed that Bio-Matrix will perform human DNA genetic testing for biomarkers that may play important roles in disease development. Vibragene anticipates sending 100,000 specimens to Bio-Matrix for testing during the next 12 months. Additionally, Bio-Matrix will supply DNA testing kits to Vibragene for the collection of DNA specimens.
Completion of the proposed agreement is subject to a number of conditions, including but not limited to, the establishment of pricing acceptable to the parties.
Source: Datamonitor
Related Articles
- 'Adipose-derived' Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Group's, Entest BioMedical Inc. Researcher
- Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
- Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
- Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
- Bio-Matrix Scientific Group Announces New Hires to Management Team
- Bio-Matrix Scientific Group, Inc. Receives and Processes First Cord Blood Specimens As Part of the Company's Quality Assurance Program
- Bio-Matrix Scientific Group, Inc. Announces It Will Open Two DNA-Genetic Testing Labs
- Tasco's Bio-Matrix Scientific Unit Installs New, Cutting-Edge Stem Cell Technology in Preparation for Anticipated September 2006 Grand Opening of Its Stem Cell Cryogenic Banking and Processing Facility
- DNA Test May Detect Prostate Cancer Early
Rating: 1.9 / 5 (7 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds